The Blood-Brain Barrier: Targeting in the Pathogenesis of C. neoformans Meningitis and Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 2211-3533|11|2|115-124

ISSN： 2211-3525

Source： Anti-Infective Agents, Vol.11, Iss.2, 2013-01, pp. : 115-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Blood-Brain Barrier: Targeting in the Pathogenesis of C. neoformans Meningitis and Drug Discovery

By Tseng Hsiang-Kuang   Huang Sheng-He   Shackleford Gregory   Jong Ambrose  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 115-124

Bentham Science Publishers

Access to resources Recommend Favorite

Blood-brain Barrier Drug Discovery for Central Nervous System Infections

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite

Drug delivery to brain via the blood-brain barrier

By Scherrmann J.-M.  

General Pharmacology, Vol. 38, Iss. 6, 2002-06 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

Drug Delivery Across the Blood-Brain Barrier

By  

Current Drug Delivery, Vol. 1, Iss. 4, 2004-10 ,pp. : 361-376

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

By Ulbrich Karsten   Knobloch Thomas   Kreuter Jörg  

Journal of Drug Targeting, Vol. 19, Iss. 2, 2011-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite